Targeting UBE2T suppresses breast cancer stemness through CBX6-mediated transcriptional repression of SOX2 and NANOG.
Wang K, He Q, Jiang X, Wang T, Li Z, Qing H, Dong Y, Ma Y, Zhao B, Zhang J, Sun H, Xing Z, Wu Y, Liu W, Guan J, Song A, Wang Y, Zhao P, Qin L, Shi W, Yu Z, Zhou H, Jiao Z.
Wang K, et al. Among authors: zhou h.
Cancer Lett. 2024 Dec 21:217409. doi: 10.1016/j.canlet.2024.217409. Online ahead of print.
Cancer Lett. 2024.
PMID: 39716485